(Q47805284)

English

Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium tuberculosis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068842

Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium tuberculosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068842

Mycobacterium tuberculosis

0 references

0 references

1 reference

based on heuristic

inferred from title

Tom H M Ottenhoff

6

object named as

Tom H M Ottenhoff

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068842

Annemieke Geluk

7

object named as

Annemieke Geluk

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068842

Kees L M C Franken

3

object named as

Kees L M C Franken

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068842

Krista E van Meijgaarden

2

object named as

Krista E van Meijgaarden

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068842

author name string

Maytal Bivas-Benita

1

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068842

Hans E Junginger

4

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068842

Gerrit Borchard

5

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068842

language of work or name

0 references

publication date

1 April 2004

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068842

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068842

22

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068842

13-14

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068842

1609-1615

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068842

Beyond BCG: the potential for a more effective TB vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.044

7 January 2021

Immunity to intracellular bacteria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.044

7 January 2021

Identification of HLA class II-restricted determinants of Mycobacterium tuberculosis-derived proteins by using HLA-transgenic, class II-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.044

7 January 2021

An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.044

7 January 2021

Vaccination against tuberculosis by DNA injection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.044

7 January 2021

Immunogenicity and protective efficacy of a tuberculosis DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.044

7 January 2021

Mycobacterial-induced cytotoxic T cells as well as nonspecific killer cells derived from healthy individuals and leprosy patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.044

7 January 2021

Stimulation of human peripheral blood mononuclear cells with live Mycobacterium bovis BCG activates cytolytic CD8+ T cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.044

7 January 2021

Analysis of local and systemic immunological responses after intra-tracheal, intra-nasal and intra-muscular administration of microsphere co-encapsulated Yersinia pestis sub-unit vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.044

7 January 2021

BCG-induced protection in guinea pigs vaccinated and challenged via the respiratory route

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.044

7 January 2021

Bronchus-associated lymphoid tissue (BALT) is not present in the normal adult lung but in different diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.044

7 January 2021

Aerogenic vaccination of mice with Mycobacterium bovis BCG

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.044

7 January 2021

Carbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.044

7 January 2021

DNA-polycation nanospheres as non-viral gene delivery vehicles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.044

7 January 2021

Chitosan as a nonviral gene delivery system. Structure-property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.044

7 January 2021

Chitosan and its use as a pharmaceutical excipient

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.044

7 January 2021

Chitosans for gene delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.044

7 January 2021

Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.044

7 January 2021

Oral gene delivery with chitosan--DNA nanoparticles generates immunologic protection in a murine model of peanut allergy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.044

7 January 2021

Intranasal gene transfer by chitosan-DNA nanospheres protects BALB/c mice against acute respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.044

7 January 2021

Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8+ T cells in HLA-transgenic mice and humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.044

7 January 2021

Human CD8+ CTL specific for the mycobacterial major secreted antigen 85A.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.044

7 January 2021

Antimicrobial activity of MHC class I-restricted CD8+ T cells in human tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.044

7 January 2021

Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.044

7 January 2021

Purification of his-tagged proteins by immobilized chelate affinity chromatography: the benefits from the use of organic solvent

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.044

7 January 2021

A method of endotracheal intubation and pulmonary functional assessment for repeated studies in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.044

7 January 2021

The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.044

7 January 2021

Inhibition of CD83 cell surface expression during dendritic cell maturation by interference with nuclear export of CD83 mRNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.044

7 January 2021

A Toll-like receptor recognizes bacterial DNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.044

7 January 2021

Generation of Toxoplasma gondii GRA1 protein and DNA vaccine loaded chitosan particles: preparation, characterization, and preliminary in vivo studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.044

7 January 2021

Identifiers

10.1016/J.VACCINE.2003.09.044

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068842

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068842

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47805284&oldid=2171546757"